FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
07/20/2024
Back to search
Official data from USPTO
NAL VON MINDEN DRUG-SCREEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NAL VON MINDEN DRUG-SCREEN
ST13
US500000079358568Class
1, 5
Filing
79358568
Registration
7312490
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/20/2024
Trademark type
Word
Nice classes
1, 5
Filing date
08/31/2022
Registration date
02/27/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/27/2024
Last transaction
02/27/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
DE
Examiner
WELCH, KATHERINE E
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
nal von minden GmbH
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Drug testing kits comprising primarily diagnostic reagents and assays for testing body fluidsother than for medical or veterinary purposes; alcohol testing kits comprising primarily diagnostic reagents and assays for testing body fluidsother than for medical or veterinary purposes
Class 5
Diagnostic and analytical substancespreparations and reagents for medical or veterinary purposesfor testing body fluids for the presence of drugs or alcohol; test strips for medical and veterinary purposesfor testing body fluids for the presence of drugs or alcohol; drug testing kits comprising primarily diagnostic reagents and assays for testing body fluids for medical purposes; alcohol testing kits comprising primarily diagnostic reagents and assays for testing body fluids for medical purposes
Publications
History of USPTO decisions and trademark events.
26 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/02/2024
FIMP
FINAL DISPOSITION PROCESSED
07/02/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/28/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/27/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/22/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/22/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2023
RFNT
REFUSAL PROCESSED BY IB
05/24/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/28/2023
RFRR
REFUSAL PROCESSED BY MPU
04/28/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/09/2023
CNRT
NON-FINAL ACTION WRITTEN
03/08/2023
DOCK
ASSIGNED TO EXAMINER
03/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
01/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/28/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/27/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/23/2022
Continuous trademark protection
Get notified about every new filing that threatens NAL VON MINDEN DRUG-SCREEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.